Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China

prnasiaJuly 20, 2020

Tag: JW Therapeutics , Syracuse Biopharma , Solid Tumor

PharmaSources Customer Service